250 related articles for article (PubMed ID: 26228432)
1. OCDB: a database collecting genes, miRNAs and drugs for obsessive-compulsive disorder.
Privitera AP; Distefano R; Wefer HA; Ferro A; Pulvirenti A; Giugno R
Database (Oxford); 2015; 2015():bav069. PubMed ID: 26228432
[TBL] [Abstract][Full Text] [Related]
2. [Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5].
Matsunaga H
Seishin Shinkeigaku Zasshi; 2012; 114(9):1023-30. PubMed ID: 23198591
[TBL] [Abstract][Full Text] [Related]
3. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).
Elliott SJ; Marshall D; Morley K; Uphoff E; Kumar M; Meader N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013173. PubMed ID: 34693989
[TBL] [Abstract][Full Text] [Related]
4. Obsessive-compulsive disorder.
Goodman WK; Grice DE; Lapidus KA; Coffey BJ
Psychiatr Clin North Am; 2014 Sep; 37(3):257-67. PubMed ID: 25150561
[TBL] [Abstract][Full Text] [Related]
5. Obsessions and Compulsions in Postpartum Women Without Obsessive Compulsive Disorder.
Miller ES; Hoxha D; Wisner KL; Gossett DR
J Womens Health (Larchmt); 2015 Oct; 24(10):825-30. PubMed ID: 26121364
[TBL] [Abstract][Full Text] [Related]
6. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates.
Lochner C; Hemmings SM; Kinnear CJ; Niehaus DJ; Nel DG; Corfield VA; Moolman-Smook JC; Seedat S; Stein DJ
Compr Psychiatry; 2005; 46(1):14-9. PubMed ID: 15714189
[TBL] [Abstract][Full Text] [Related]
7. A review of the role of serotonin system genes in obsessive-compulsive disorder.
Sinopoli VM; Burton CL; Kronenberg S; Arnold PD
Neurosci Biobehav Rev; 2017 Sep; 80():372-381. PubMed ID: 28576508
[TBL] [Abstract][Full Text] [Related]
8. ChemiRs: a web application for microRNAs and chemicals.
Su EC; Chen YS; Tien YC; Liu J; Ho BC; Yu SL; Singh S
BMC Bioinformatics; 2016 Apr; 17():167. PubMed ID: 27091357
[TBL] [Abstract][Full Text] [Related]
9. The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder.
Wu K; Hanna GL; Rosenberg DR; Arnold PD
Pharmacol Biochem Behav; 2012 Feb; 100(4):726-35. PubMed ID: 22024159
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review of Scientific Studies and Case Reports on Music and Obsessive-Compulsive Disorder.
Truong TPA; Applewhite B; Heiderscheit A; Himmerich H
Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831558
[TBL] [Abstract][Full Text] [Related]
11. An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder.
van de Vondervoort I; Poelmans G; Aschrafi A; Pauls DL; Buitelaar JK; Glennon JC; Franke B
J Psychiatry Neurosci; 2016 Jun; 41(4):280-5. PubMed ID: 26854754
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Piccinelli M; Pini S; Bellantuono C; Wilkinson G
Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
[TBL] [Abstract][Full Text] [Related]
13. Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis.
De Prisco M; Tapoi C; Oliva V; Possidente C; Strumila R; Takami Lageborn C; Bracco L; Girone N; Macellaro M; Vieta E; Fico G
Eur Neuropsychopharmacol; 2024 Mar; 80():14-24. PubMed ID: 38128332
[TBL] [Abstract][Full Text] [Related]
14. Phenomenology of OCD: lessons from a large multicenter study and implications for ICD-11.
Shavitt RG; de Mathis MA; Oki F; Ferrao YA; Fontenelle LF; Torres AR; Diniz JB; Costa DL; do Rosário MC; Hoexter MQ; Miguel EC; Simpson HB
J Psychiatr Res; 2014 Oct; 57():141-8. PubMed ID: 25012187
[TBL] [Abstract][Full Text] [Related]
15. Obsessive-Compulsive Symptoms in Obsessive-Compulsive Disorder and in Generalized Anxiety Disorder: Occurrence and Correlations.
Citkowska-Kisielewska A; Rutkowski K; Mielimąka M; Sobański JA; Dembińska E
J Psychiatr Pract; 2020 Mar; 26(2):101-119. PubMed ID: 32134883
[TBL] [Abstract][Full Text] [Related]
16. A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.
Grados M; Prazak M; Saif A; Halls A
Expert Opin Drug Discov; 2016; 11(1):27-43. PubMed ID: 26558411
[TBL] [Abstract][Full Text] [Related]
17. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
[TBL] [Abstract][Full Text] [Related]
18. Advances in the pharmacological management of obsessive-compulsive disorder in the postpartum period.
Brakoulias V; Viswasam K; Dwyer A; Raine KH; Starcevic V
Expert Opin Pharmacother; 2020 Feb; 21(2):163-165. PubMed ID: 31893946
[No Abstract] [Full Text] [Related]
19. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.
Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M
Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis.
Hadi F; Kashefinejad S; Kamalzadeh L; Hoobehfekr S; Shalbafan M
BMC Pharmacol Toxicol; 2021 Nov; 22(1):69. PubMed ID: 34736541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
